A conversation about what comes next
Where sound and AI meet CGMPs, and CGMPs meet practice — in pharma and beyond.
Knowledge, in the mix.
Latest episodes · Sponsored by Tailwind Pharma
Nov 2, 2026
The investigator leaves and someone says, "Well, glad that's over." That is usually your cue to reopen the action tracker. When the FDA walks out your door, who actually decides your facility’s fate? Is it the field investigator who walked the cleanroom, or an office at White Oak you’ve never seen?
01 / The conversation
A pharmaceutical regulatory affairs podcast for the people responsible for quality—and anyone curious about the rules behind medicines.
The Regulatory Mix brings FDA guidance, current Good Manufacturing Practices, and public enforcement actions into focus. Episodes pair clear overviews with deeper analysis of the documents and developments shaping pharmaceutical manufacturing and compounding.
For seasoned professionals and quality-minded newcomers alike, the aim is practical context without losing the nuance that matters.
01 / Credible
Grounded in public documents.
02 / Curious
Open to the questions that matter.
03 / Clear
Context you can carry into your work.
02 / In the mix
The issues behind today’s quality decisions. Each topic is approached as a working question for regulated teams—not simply a headline or a summary of agency language.
Clear overviews of the documents, expectations, and policy shifts shaping pharmaceutical quality and regulatory work.
Practical discussion of public FDA actions and what the underlying observations can teach quality and operations teams.
Focused analysis of current Good Manufacturing Practices, inspection readiness, data integrity, and quality-system execution.
Noteworthy developments affecting manufacturers, CDMOs, and the 503A and 503B compounding environment.
03 / Take the insight with you
Follow the show in your podcast app, keep up on LinkedIn, or subscribe through RSS.
From conversation to consulting
The podcast provides general information. For a specific inspection, FDA observation, enforcement response, or complex quality decision, Tailwind Pharma provides direct consulting support.